CORRECTION article

Front. Pharmacol., 04 October 2021
Sec. Ethnopharmacology
https://doi.org/10.3389/fphar.2021.774792

Corrigendum: Bazi Bushen Capsule Alleviates Post-Menopausal Atherosclerosis via GPER1-Dependent Anti-Inflammatory and Anti-Apoptotic Effects

www.frontiersin.orgDan Huang1,2, www.frontiersin.orgXindong Wang1,2, www.frontiersin.orgYunhong Zhu1,2, www.frontiersin.orgJuexiao Gong1,2, www.frontiersin.orgJunqing Liang3, www.frontiersin.orgYanfei Song3, www.frontiersin.orgYiyan Zhang1,2, www.frontiersin.orgLinsheng Liu4* and www.frontiersin.orgCong Wei3*
  • 1Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China
  • 2Jiangsu Province Academy of Traditional Chinese Medicine, Nanjing, China
  • 3National Key Laboratory of Collateral Disease Research and Innovative Chinese Medicine, Shijiazhuang, China
  • 4Department of Clinical Pharmacology, The First Affiliated Hospital of Soochow University, Suzhou, China

A Corrigendum on
Bazi Bushen Capsule Alleviates Post-Menopausal Atherosclerosis via GPER1-Dependent Anti-Inflammatory and Anti-Apoptotic Effects

by Huang, D., Wang, X., Zhu, Y., Gong, J., Liang, J., Song, Y., Zhang, Y., Liu, L., and Wei, C. (2021). Bazi Bushen Capsule Alleviates Post-Menopausal Atherosclerosis via GPER1-Dependent Anti-Inflammatory and Anti-Apoptotic Effects. Front. Pharmacol. 12:658,998. doi:10.3389/fphar.2021.658998

In the original article, there was a mistake in Table 1 as published. BZBS is a post-marketing drug, and there is an error in the components of BZBS and ratio amounts in application (Li et al., 2021). The corrected Table 1 appears below.

TABLE 1
www.frontiersin.org

TABLE 1. The ratio of the plants present in the preparation of BZBS.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Reference

Li, L., Chen, B., An, T., Zhang, H., Xia, B., Li, R., et al. (2021). BaZiBuShen Alleviates Altered Testicular Morphology and Spermatogenesis and Modulates Sirt6/P53 and Sirt6/NF-Κb Pathways in Aging Mice Induced by D-Galactose and NaNO2. J. Ethnopharmacol 271, 113810. doi:10.1016/j.jep.2021.113810

CrossRef Full Text | Google Scholar

Keywords: atherosclerosis, bazi bushen capsule, lipid profile, inflammation, GPER1 antagonist, apoptosis

Citation: Huang D, Wang X, Zhu Y, Gong J, Liang J, Song Y, Zhang Y, Liu L and Wei C (2021) Corrigendum: Bazi Bushen Capsule Alleviates Post-Menopausal Atherosclerosis via GPER1-Dependent Anti-Inflammatory and Anti-Apoptotic Effects. Front. Pharmacol. 12:774792. doi: 10.3389/fphar.2021.774792

Received: 13 September 2021; Accepted: 17 September 2021;
Published: 04 October 2021.

Edited and reviewed by:

Hongzhi Du, Hubei University of Chinese Medicine, China

Copyright © 2021 Huang, Wang, Zhu, Gong, Liang, Song, Zhang, Liu and Wei. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Linsheng Liu, linsheng_liu@126.com; Cong Wei, weicong@yiling.cn

Download